Viewing Study NCT01978093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2026-03-02 @ 7:44 AM
Study NCT ID: NCT01978093
Status: COMPLETED
Last Update Posted: 2018-09-14
First Post: 2013-10-31
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neisseria Meningitidis View
None Haemophilus Influenzae Type b View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Conjugate View
None Immunogenicity View
None Hib-MenCY-TT vaccine View
None Haemophilus type b View
None Safety View
None Reactogenicity View